MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202617086261 A) filed by Biopharmaceutical Research Company on July 14, 2026, for Cannabinoid Compositions For Treatment Of Post-Traumatic Epilepsy.
Inventors include Land, Michael Hunter; Brandley, Brian Kent; Hodgin, George Bennett; Zumstein, Lucas J.; and Kulpa, Justyna.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: Cannabinoid compositions formulated for use in the treatment of post-traumatic epilepsy (PTE) are disclosed. The compositions include cannabidiol (CBD), cannabigerol (CBG), and tetrahydrocannabinol (THC) as the major components therein, which may be isolated, purified or extracted from cultivars and blended together. The compositions include CBD, CBG and THC in certain ratios, formulated for the use in the treatment of PTE.
Disclaimer: Curated by HT Syndication.
